Alkermes (ALKS) Change in Cash (2010 - 2026)
Alkermes (ALKS) posted quarterly Change in Cash of $160.0 million for Q2 2026, up 31.79% year-over-year from $121.4 million in Q2 2025, and up 120.82% quarter-over-quarter from -$768.2 million in Q1 2026.
Alkermes (ALKS) Change in Cash (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Change in Cash for 17 consecutive years, with $160.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Cash rose 31.79% year-over-year to $160.0 million; the TTM figure through Jun 2026 stood at -$9.7 million (up 30.69% YoY), while the FY2025 annual figure was $828.6 million, up 598.21% from the prior year.
- Change in Cash improved to $160.0 million in Q2 2026 per ALKS's latest filing, from -$768.2 million in the prior quarter.
- Across five years, Change in Cash topped out at $503.3 million in Q4 2025 and bottomed at -$768.2 million in Q1 2026.
- Historically, Change in Cash has averaged $9.7 million across 5 years, with a median of $18.9 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Cash surged 1333.9% — and 2026, when it tumbled 807.0%.
- Alkermes' Change in Cash stood at $28.5 million in 2022, then sank by 767.14% to -$190.2 million in 2023, then jumped by 44.73% to -$105.1 million in 2024, then soared by 578.69% to $503.3 million in 2025, then tumbled by 68.22% to $160.0 million in 2026.
- Business Quant data shows ALKS's Change in Cash at $160.0 million in Q2 2026, -$768.2 million in Q1 2026, and $503.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 159.98 Mn |
| Mar 31, 2026 | -768.23 Mn |
| Dec 31, 2025 | 503.33 Mn |
| Sep 30, 2025 | 95.25 Mn |
| Jun 30, 2025 | 121.39 Mn |
| Mar 31, 2025 | 108.66 Mn |
| Dec 31, 2024 | -105.15 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Jun 30, 2024 | 114.40 Mn |
| Mar 31, 2024 | -36.72 Mn |
| Dec 31, 2023 | -190.24 Mn |
| Sep 30, 2023 | -18.08 Mn |
| Jun 30, 2023 | 344.39 Mn |
| Mar 31, 2023 | 28.93 Mn |
| Dec 31, 2022 | 28.52 Mn |
| Sep 30, 2022 | 9.31 Mn |
| Jun 30, 2022 | -27.91 Mn |
| Mar 31, 2022 | -54.99 Mn |
| Dec 31, 2021 | 27.10 Mn |
| Sep 30, 2021 | 52.10 Mn |